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Abstract
Background: The increasing use of the ketogenic diet (KD), particularly by women of child-bearing age, raises a
question about its suitability during gestation. To date, no studies have thoroughly investigated the direct
implications of a gestational ketogenic diet on embryonic development.
Methods: To fill this knowledge gap we imaged CD-1 mouse embryos whose mothers were fed either a Standard
Diet (SD) or a KD 30 days prior to, as well as during gestation. Images were collected at embryonic days (E) 13.5 using
Optical Projection Tomography (OPT) and at E17.5 using Magnetic Resonance Imaging (MRI).
Results: An anatomical comparison of the SD and KD embryos revealed that at E13.5 the average KD embryo was
volumetrically larger, possessed a relatively larger heart but smaller brain, and had a smaller pharynx, cervical spinal
cord, hypothalamus, midbrain, and pons, compared with the average SD embryo. At E17.5 the KD embryo was found
to be volumetrically smaller with a relatively smaller heart and thymus, but with enlarged cervical spine, thalamus,
midbrain and pons.
Conclusion: A ketogenic diet during gestation results in alterations in embryonic organ growth. Such alterations
may be associated with organ dysfunction and potentially behavioral changes in postnatal life.
Keywords: Ketogenic diet, Low-carbohydrate diet, Embryonic development, CD-1 mouse, Mouse imaging, Optical
projection tomography, Magnetic resonance imaging
Background
The Ketogenic Diet (KD) is a high fat, low carbohydrate,
adequate protein diet, which has been gaining support
as a lifestyle diet for weight maintenance [1] and body-
building purposes in healthy adults [2]. Classically, the
diet has been primarily used as a therapeutic measure for
intractable pediatric epilepsy. However, due to its high
efficacy and significant advantages over anti-epileptic
medications, adult epileptic patients are recently adopt-
ing it as well. Its increased and prolonged use by adults,
and specifically women, raises a question about its safety
as a gestational diet. Gestational diets determine mater-
nal nutrition, which is transmitted to the fetus through the
placenta [3,4]. An insufficient or inappropriate gestational
diet can cause permanent deleterious effects to maternal
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and fetal metabolism [5], leading to altered fetal phys-
iology. The relationship between a gestational diet and
fetal physiology is often referred to as “fetal developmental
adaptation” [6-9]. The resulting altered fetal metabolism
and physiology can affect organ development and func-
tion. In fact, such alterations in metabolism and physiol-
ogy have been shown to predispose the fetus to multiple
metabolic, endocrine, cardiovascular, mental, and cogni-
tive disorders in adult life [10,11]. Thus, it is important
to investigate whether a KD negatively impacts prenatal
organ development to determine the safety and suitability
of a KD during pregnancy.
Previous studies of gestational ketosis focused on keto-
sis as resulting from maternal malnutrition, prolonged
fasting, or diabetes. These, however, are different than the
stable ketosis that results from consumption of a keto-
genic diet (KD) that is of adequate energy and nutrients.
The mouse is a convenient and commonly used model
for studying the effects of environmental factors, includ-
ing nutrition, on mammalian developmental. The mouse
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genome has been fully sequenced and was found to share
a high degree of homology with the human genome. Such
homology suggests that studying the physiological effects
of a KD on mouse development, may shed light on the
potentially-similar effects on human development. In the
current study we compare the growth of mouse embryos
on a KDwith that of embryos on a Standard Diet (SD), and
utilize three-dimensional (3D) imaging and quantification
to test whether statistically significant diet-induced differ-
ences are evoked in prenatal organ and body growth. 3D
imaging is a non-invasive, non-destructive technique that
allows to identify patterns and analyze complex anatom-
ical geometry within the mouse embryo. Optical Pro-
jection Tomography (OPT) was chosen for imaging the
E13.5 embryos due to its fine spatial resolution of 20μm.
However, OPT is limited to spatial coverage of about
(1-2cm)3, as well as by tissue opacity which becomes
significant beyond E14.5 [12]. Thus, to image the E17.5
embryos we utilized Magnetic Resonance Imaging (MRI)
which provided a 56μm isotropic resolution.
Methods
Six-week-old CD-1 male and female mice were weight-
matched and randomly assigned to either a control group
(SD), or a study group (KD). Mice were fed their respec-
tive diets for a period of 30 days, and then naturally mated
by setting up a single male with a single female from
their respective group. The morning a copulation plug
was observed was considered day 0.5 of gestation. The
mated dams were allowed to reach embryonic (E) day
E13.5 or E17.5 days post-conception, corresponding to the
end of organogenesis and fetal growth, respectively [13].
At these time-points the pregnant dams were euthanized
and several of their embryos were harvested for imag-
ing. In both dietary groups, all embryos appeared viable,
had no obviousmalformations, and the selected ones were
chosen arbitrarily.
Diet
Both the Standard Diet (SD) and the Ketogenic Diet
(KD) were manufactured by Harlan (Madison, WI). SD
consisted of 5% fat, 76.1% carbohydrate, and 18.9% pro-
tein, wt/wt (Teklad diet no. TD.2918), whereas KD con-
sisted of 67.4% fat, 0.6% carbohydrate, and 15.3% protein
wt/wt, which is equivalent to a 4:1 ratio by weight of fat
to combined protein and carbohydrate (Teklad diet no.
TD.96355) [14]. The fatty-acid profiles of the SD / KD,
respectively, are as follows: % Saturated Fatty Acids (SFA):
0.9 / 15.90, %Monounsaturated Fatty Acids (MUFA): 1.3 /
25.80, % Polyunsaturated Fatty Acids: 3.4 / 24.35. While
the SDmeets the nutritional needs of the pregnant mouse,
the suitability of the KD during gestation has not been
fully elucidated. During the initial 30-day feeding period,
mice in the control group were kept on a standard rodent
diet (SD), and mice in the study group were gradually
introduced to the KD to facilitate gradual adaptation and
metabolic shift from glycolysis to ketosis. The introduc-
tion of the KD was conducted over a 10-day period, after
which the KD mice were given only the pure KD during
the remaining 20 days in the feeding period. Preliminary
studies showed that ketone values had stabilized by 4
weeks (not shown); hence, mating was performed at that
time-point in all experiments.
Animals
All animal procedures in this study were carried out in
accordance with the Canadian Council on Animal Care,
and approved by the Animal Care Committee of the
Toronto Centre for Phenogenomics (TCP). During the 30-
day feeding period, physiological and metabolic param-
eters were assessed in the first 20 animals per dietary
group to determine whether the KD mice reached a
stable-state ketosis within that time frame. Body weight,
blood glucose and β−ketones (β −hydroxybutyrate) were
measured weekly, using an Abbott “Precision Xtra” glu-
cometer which required a relatively minute blood volume
of 0.6-1.5 μL/test [15] drawn from the tail vein. Choles-
terol and triglycerides were tested at the end of the feeding
period, and required a combined whole-blood volume
of 190 μL, collected from the saphenous vein. During
gestation, weekly body weight and glucometer testing
were measured in all mice. Metabolic data was statisti-
cally analyzed for changes over time and between dietary
groups using Analysis of Variance (ANOVA) with a linear
model [16].
Imaging
All embryos were fixed for 24 hours in 4% para-
formaldehyde. The E13.5 embryos were then embedded in
1% low melting temperature agar which was subsequently
dehydrated in methanol and cleared in BABB (a 2:1 mix-
ture of Benzyl-Benzoate:Benzyl-Alcohol) prior to being
imaged with OPT using auto-fluorescence mode [17]. The
fixed E17.5 embryos were immersed in PBS containing 4%
Gadolinium (“ProHance” gadoteridol by Bracco Diagnos-
tics) for 3 days, after which they were embedded in high
melting temperature agar containing 4% Gd, and then
imaged with MRI, using a T2-weighted, 3D fast-spin echo
sequence.
An example of an embryo image is depicted in Figure 1,
along with labeling of several anatomical structures.
Image statistical analysis
For each of the two time-points, homologous points
within all SD and KD images were detected, aligned with
respect of one another, and saved within a common coor-
dinate system. The overlapping images were then trans-
formed into a single consensus average that accurately















Figure 1 An image of an E17.5 mouse embryo with selected
anatomical structures labeled.
identified the anatomical correspondence between the
different images. This transformation followed a multi-
step process. The first step linearly aligned all images
through a series of rotations, translations, scales, and
shears. The second step used an iterative non-linear align-
ment procedure that created local deformations in each
image that brought all images into exact correspondence.
The collection of all linear and non-linear deformations
across each image formed a deformation field, which was
the transformation from each individual image of mouse
embryo anatomy to the consensus average image. To
reveal any local changes in each image with respect to the
consensus average image, the determinant of each defor-
mation field, known as the Jacobian, was computed for
each image voxel (i.e. 3D pixel). These Jacobians were
then analyzed statistically to determine whether the KD
embryos significantly differed from the SD (control) ones
in any particular 3D region. This analysis is referred to as a
deformation-based analysis, and its results are reported as
an imge overlaid with a red / blue color scale-bar indicat-
ing the significant t-statistics values of the corresponding
voxels. To also investigate group-differences between vol-
umes of specific organs, outlines of chosen organs were
traced (segmented) in the average image, thereby isolating
them in 3D space. To map these regions back to the origi-
nal individual images and compute their original volumes,
the Jacobian determinant was used: it was integrated, mul-
tiplied by the voxel size of the voxels residing within the
organ [18]. This volume analysis will be referred to as an
organ-based analysis. To correct for multiple comparisons
in these analyses, a False Discovery Rate (FDR) method
was utilized [19,20], and is reported along with the results.
Results
Metabolic status of pre-mated female mice
Average body weight and blood glucose of KD female
mice did not statistically differ from those of SD female
mice (p > 0.1) prior to mating. However, prior to mat-
ing, the serum ketone and cholesterol concentrations of
KD female mice were significantly elevated, and their
serum triglyceride concentrations were significantly lower
compared with those of SD female mice (p < 0.05), as
anticipated for the KD diet (Table 1).
Embryonic imaging
A significant size difference was observed during imag-
ing of E13.5 KD and SD embryo, as depicted in Figure 2.
This figure also depicts the final average embryo image,
constructed using all SD and KD embryos (57 embryos
in total), which retained its high resolution during regis-
tration. To assess the animal-to-animal variation among
the SD mice, the outlines of all linearly-aligned SD images
were overlaid on top of a white mask of the final E13.5
average image. This is depicted in Figure 3.
A notable size difference between KD and SD embryos
was also observed at E17.5, as shown in Figure 4. How-
ever, unlike at E13.5, at this time point the KD embryo
was found to be smaller than its SD counterpart. The
average embryo image constructed using all (20) SD and
KD embryos appears in Figure 4A. Note that the high
resolution was maintained during image registration of
embryos.
An organ-based analysis on the average embryos
revealed that at E13.5 the KD embryo was larger than the
SD counterpart by 37% (p < 0.05), while at E17.5 the KD
embryo was smaller than the SD one by 20% (p < 0.05).
These differences are depicted in the graph in Figure 5,
which shows the volume inmm3.
The same organ-based analysis was carried out on
selected internal organs: the brain, heart, and liver. This
analysis allowed us to compute the organ volume as a
percentage of the embryo volume. These calculations
revealed that the KD brain occupied a smaller percentage
of the embryo volume at E13.5, as compared with the SD
brain (p < 0.05), but a larger percentage volume at E17.5
(p < 0.05). This result suggests that the growth of the KD
brain is shifted towards late pregnancy compared with the
growth of the SD brain, but at that point it also exceeds
the SD brain growth.
Unlike the brain, the KD heart was found to occupy
a larger percentage volume compared with the SD heart
at E13.5 (p < 0.05), but an equivalent percentage vol-
ume at E17.5 (p > 0.05). Hence, the dis-proportionality
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Table 1 Body weight and bloodmetabolites of female SD and KDmice
Weight Glucose Ketone Cholesterol Triglyceride Num. of
[gr] [mmol/L] [mmol/L] [mmol/L] [mmol/L] embryos
Prior to SD 29.5 ± 0.5 (20) 6.4 ± 0.3 (20) 0.25 ± 0.02 (20) 3.4 ± 0.2 (20) 2.1 ± 0.2 (20) -
Mating KD 30.8 ± 0.7 (20) 5.3 ± 0.2 (20) * 1.94 ± 0.15 (20) * 4.4 ± 0.2 (17) * 1.8 ± 0.1 (17) * -
At E13.5 SD 45.0 ± 1.3 (11) 7.0 ± 0.5 (11) 0.22 ± 0.04 (11) 2.8 ± 0.1 (10) 2.8 ± 0.2 (10) 12.9 ± 0.6 (17)
KD 45.4 ± 1.2 (11) 6.6 ± 0.5 (11) 1.57 ± 0.23 (11) * 3.6 ± 0.2 (11) * 5.1 ± 1.1 (11) * 12.1 ± 1.0 (12)
At E17.5 SD 67.1 ± 1.7 (19) 5.9 ± 0.3 (12) 0.27 ± 0.04 (11) 2.0 ± 0.1 (13) 2.7 ± 0.3 (13) 10.9 ± 1.2 (8)
KD 58.9 ± 1.1 (18) * 2.8 ± 0.2 (11) * 3.96 ± 0.30 (11) * 2.8 ± 0.3 (12) * 7.8 ± 1.8 (12) * 11.3 ± 0.6 (6)
p-value Diet 0.0094 < 0.0001 < 0.0001 < 0.0001 0.0569 –
Time-pt < 0.0001 0.0055 0.0001 < 0.0001 0.0011 –
Interaction 0.0008 0.0411 0.0001 0.0273 0.0481 –
Values were measured just prior to mating, at E13.5 and at E17.5 (Mean ± SEM (Number of dams tested)). Statistically significant KD vs. SD p-values are indicated by a
(*) for comparison at each time point.
between the KD heart and embryo volumes at E13.5 no
longer existed at E17.5, suggesting the KD heart growth
exceeds that of the SD heart during organogenesis but not
afterwards. The KD liver was found to occupy the same
percentage volume of the embryo at both time-points
(p > 0.05), indicating the KD liver volume grew propor-
tionally to the embryo volume both during as well as
post organogenesis. The percentage organ volume for the
different organs is summarized in Figure 6.
Deformation-based analysis
More localized anatomical changes were detected via a
deformation-based analysis conducted on the deforma-
tion maps. This analysis at E13.5 revealed that, when
compared with the SD embryo, the KD embryo had
a decreased relative volume within the pharynx, the
cervical spinal cord, and cerebral thalamus region, as
well as in the upper hepatic region. Increased rela-
tive volume was detected in the lateral wall of the
left ventricle of the heart as well as in the skeletal
muscle, as shown in Figure 7. Large variations in the
position of the tail and limbs with respect to the
embryo body existed in the images, arising from embryo
positioning within the agar. This could have caused
errors in the image registration of the tail and limbs
and, as such, they were excluded from the statistical
analysis.
A deformation-based analysis at E17.5 indicated that
the KD mouse had an increase in volume in several brain
regions and in the cervical spine, and a decrease in volume
in the right lobe of the thymus, as shown in Figure 8.
A more detailed examination of the KD brain at the two
time points revealed that the mid-brain and pons were
smaller in relative volume at E13.5, but larger in relative
volume at E17.5 (Figure 9). Additionally, the hypotha-
lamus was smaller in relative volume at E13.5, and the
thalamus was enlarged at E17.5, whereas these regions
were not statistically different at the other time-points.
Overall, this result is consistent with differences in overall
brain size found using organ-based analysis. However, it
A B C1mm
Figure 2 Embryonic size difference at E13.5. (A) A consensus average of all E13.5 embryos constructed using the SD and KD OPT embryo images
(N = 59), followed by separate averages of (B) all SD (N = 27) and (C) all KD (N = 32) E13.5 embryos. The outline of the KD embryo is traced in yellow
in (b) to illustrate the overall size difference compared with the SD embryo.
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Figure 3 An illustration of the animal-to-animal variation within
the SD group at E13.5. The coloured traces are outlines of all
linearly-aligned individual SD images, and the white region is a mask
of the final average image.
further reveals that specific brain regions show altered
growth due to the maternal consumption of KD.
Discussion
Our study first reveals the organ sizes of the mouse
embryo at several time-points during development. These
values, calculated in percentage volume, are summarized
in Table 2, and are compared with the corresponding
organ weight as percent of body weight for the adult 16
week-old mouse [21].
The data reveal that the brain, heart and liver occupy
a relatively large percentage of the mouse embryo’s vol-
ume at the end of organ development (E13.5). While the
percentage volume of the liver decreases slowly towards
parturition (E17.5), the corresponding percentages of
the brain and heart decrease much more drastically. A
comparison with percentage organ weight of an adult
16-week-old mouse reveals that the organ-to-body pro-
portionality continues to decrease significantly post-
natally.
Our study also compares how organ growth in the
mouse is altered by maternal consumption of a ketogenic
diet during pregnancy. Results show an overall increase
in volume of the KD embryo at E13.5, but a significant
decrease at E17.5, compared with the SD counterpart. At
these time points, the KD heart and brain occupied a dif-
ferent percentage volume compared with the SD organs.
Additionally, differences revealed by deformation analy-
sis within internal organs were also observed at the two
time points, particularly in the pharynx, cervical spinal
cord, hypothalamus, thalamus, thymus, mid-brain, pons,
left ventricle and in several regions in the liver.
Maternal consumption of KD prior to gestation was
found to decrease serum triglycerides in the mouse. This
result is similar to that reported by others utilizing the
mouse [22]. In contrast, the KD was found to increase
triglycerides in the human [23], indicating that the rate
of utilization of fat-stores for energy may be different
between the two species. However, this needs to be fur-
ther investigated.
Serum glucose was also found to be reduced, while
cholesterol and ketone concentrations were found to be
significantly elevated in the KD dams prior to gestation.
These changes are as expected during a stable state of
ketosis, in which fat intake - including cholesterol intake -
A B2mm C
Figure 4 Embryonic size difference at E17.5. (A) A consensus average of all E17.5 embryos constructed using the SD and KD MRI embryo images
(N = 20), followed by separate averages of (B) all SD (N = 10) and (C) all KD (N = 10) E17.5 embryos. The outline of the SD embryo is traced in yellow
in (c) to illustrate the overall size difference compared with the KD embryo.














































Figure 5 Embryo volume (Mean±Stdv) inmm3 at E13.5 (NSD = 27, NKD = 32) and E17.5 (NSD = NKD = 10). (*) indicates p < 0.05.
is consistently high, and carbohydrate intake is consis-
tently low [2,24,25]. All of these metabolites continued to
change in the KD dams during pregnancy, with maternal
glucose dramatically dropping, while ketone and triglyc-
erides - drastically increasing between E13.5 and E17.5,
towards the end of pregnancy. This trend suggests an
increase in nutrient demand by the mature fetus, driving
maternal metabolism towards high ketosis. Such a state of
high ketosis increases the probability of ketoacidosis in the
KD dams since any further drop in glucose could trigger
more rapid gluconeogenesis, elevating ketones to dan-
gerously high levels, and thus, preventing the utilization
of the already-elevated serum ketones. While ketoaci-
dosis was not observed in any of the KD dams during
pregnancy, the high ketosis, and particularly the dramat-
ically low maternal blood glucose, could have been the
cause of the altered growth exhibited at E17.5. This dele-
terious effect could have impacted those organs which
preferentially use glucose as a source of energy.
While this ketone (β−hydroxybutyrate) can lead to a
risky metabolic state, it is in fact a natural product of
fat metabolism [26], which also serves as a metabolic
fuel [27,28]. Since maternal ketones easily cross the pla-
centa [29,30], they should be similarly utilized by the
fetus to satisfy its energy requirement during develop-
ment [27,28]. If that were indeed the case, then one
could naively predict that during a stable, prolonged
maternal ketosis, fetal growth would be unaltered, and
remain equivalent to that duringmaternal glycolysis. This,
however, neglects to consider the inherent differences
between glycolysis and ketosis. While ketones can satisfy
energetic requirements, their efficiency as ametabolic fuel
is different than that of glucose. In fact, ketones’ effi-
ciency, as measured by oxygen consumption, has been
shown to be 25% greater than that of glucose, indi-
cating a significantly greater energy production during
ATP hydrolysis [31-33]. Such increased efficiency may
then be counteracted by the inhibitory effect of ketones
on de novo pyrimidine synthesis, which can slow the
rate of cellular growth, as shown in Koehler et al’s
in vitro studies (described in [24]). The net result of
these opposing actions on embryonic development and
fetal growth would then depend on the exact nutri-
ent and energetic demand at any particular develop-
mental phase. Specifically, a positive net effect could
explain the increase in embryonic volume, observed
at E13.5, yet, a negative – or inhibitory – net effect
could, in turn, explain the decrease in embryonic vol-
ume, observed at E17.5. Internal organs are potentially
also subjected to the same counteracting forces, resulting
in altered timing of growth spurts, which could explain
the altered KD brain and heart percentage volume at
E13.5 and E17.5.
Different effects of KD on organ growth may be
explained by organ-specific preference for a particular
metabolic fuel. Under non-ketotic conditions, the fetal
myocardium has been shown to prefer fatty acids, glucose
and lactate over ketones as its major energy substrates
[34,35]. This preference, as measured by substrate uti-
lization rate, was found to primarily depend on relative
substrate availability (concentration) [34]. When ketosis
was induced by an over-night fast, the neonatal lamb
myocardium increased its βOHB oxidation in response to
the increase in ketone supply. A similar increase in βOHB
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Figure 6 Percentage volume (Mean±Stdv) occupied by the brain, heart, and liver at E13.5 (NSD = 27, NKD = 32) and E17.5 (NSD = NKD =
10). (*) indicates p < 0.05.
oxidation was reported in the brain of the swine fetus fol-
lowing maternal ketosis [36]. In the fetal pig, the brain
was also found to increase in weight, protein content and
cell size following maternal ketosis [37]. Yet, even inde-
pendently of maternal ketosis, the developingmouse brain
and spinal cord appear to preferentially utilize ketone bod-
ies as an energy source, and as precursors of amino-acid
and lipid synthesis [38,39]. In particular, the rat brain –
specifically, the striatum and cortex – were found to have
a significantly higher βOHB tissue concentration in late
gestation and early postnatal period than at adulthood
[40]. Unlike the heart and brain, the fetal liver has been
reported to only increase its rate of lipogenesis, but not its
rate of βOHB oxidation (i.e. degradation), during mater-
nal ketosis [36]. The potential implication of this is a more
rapid triglyceride synthesis, but with a preference for fat
deposition in the liver, that could result in an increase in
hepatic volume. This, however, was not observed in our
KDmice, suggesting the effect of hepatic fat deposition on
hepatic volume is insignificant.
Ketone bodies in maternal circulation cross the placenta
so that they are available as an energy substrate for fetal
use throughout gestation [30]. However, such availability
depends on the ketone body carriers, known as Mono-
carboxylate Transporters (MCTs) [41,42]. Studies using
non-ketogenic gestational diet revealed that the expres-
sion of MCT in the placenta decreases at the end of
gestation, while the expression of the glucose transporter
GLUT1 remains consistently high throughout gestation
[29]. This observation suggests that assuming ketolytic
enzymes are available to facilitate ketone oxidation [43],
then the fetal mouse utilizes both glucose and ketone in















Figure 7 T-statistics map overlaid on top of the registered E13.5 embryo image, highlighting voxels in the KD embryos that had
statistically different deformations compared with those of the SD embryos (FDR≤ 10%). Red regions are statistically larger in the KD
embryo, whereas blue regions are statistically smaller in the KD compared with the SD embryo.
early and mid gestation. However, it preferentially uti-
lizes glucose towards the end of gestation, when rapid
physiological growth is occuring. In the case of the fetal
brain, ketone utilization primarily depends on its con-
centration in the blood [39]. Hence, prolonged fasting or
consumption of a high-fat diet, such as a ketogenic diet,
increases the blood-brain barrier’s permeability to ketones
[39,44,45].
Our observation that the KD embryonic volume as
well as myocardium and hepatic percentage volumes were
larger than the respective SD ones at E13.5 but not at
E17.5 are consistent with the above literature on βOHB
oxidation and supply, as modulated by MCT expres-
sion. The observation of a localized increase in mid-brain
volume in the KD fetus at E17.5, is also in agreement
with the studies indicating a strong preference for βOHB
as an energy substrate towards the end of gestation [40],
as well as with the observation of the increase in fetal
brain weight [37]. The high PUFA contents in the KDmay
result in PUFA accumulation in the brain at the end of
gestation, and explain the increased brain volume. This
is in agreement with observations by Soares et al. (2009)
[46]. The increase in skeletal muscle volume observed at














Figure 8 T-statistics map overlaid on top of the registered E17.5 embryo image, highlighting voxels in the KD embryo that had
statistically different deformations compared with those of the SD embryo (FDR≤ 10%). Red regions are statistically larger in the KD embryo,
whereas blue regions are statistically smaller in the KD compared with the SD embryo.




































Figure 9 E13.5 and E17.5 brain regions that are statistically different in the KD compared with the SD embryos. The top and bottom panels
show several selected cross-sections centered around the slices depicted in the 3D rendering. T-statistics color-bar corresponds to a FDR≤ 10%.
the localized differences indicated by the deformation
analysis within internal organs could arise from inho-
mogeneous energy supply to those sub-regions, or their
preference for a different metabolic fuel during their
growth.
Another possible cause of the observed differences
between the KD and SD embryos may be the inherent
difference in macronutrient and micronutrient contents
of the respective diets. For example, the KD is high in
dietary trans-fatty acids. Studies have indicated a spec-
ulative correlation between such high gestational intake
of trans-fatty acids and compromised fetal growth and
development [47]. In our study, the exact contents of trans
fatty-acids was not measured, but may contribute to the
observed differences between the KD and SD embryos.
Hence, we do not exclude the possibility that some of the
observed alterations may be attributed to the differences
in micro- and macronutrient intake.
Overall the differences revealed by deformation analysis
suggest a deviation from the normal organ development
at the end of embryogenesis, which could lead to altered
organ function in postnatal life. Specifically, the decrease
in relative volume of the right lobe of the thymus, as well
as the increase in relative volume in the thalamus, mid-
brain, and pons at E17.5 may be indicative of functional
Table 2 Organ-to-body ratio in the SDmouse embryo
compared with the adult mouse
E13.5 E17.5 16 wks postnatally
Brain 24.06 ± 0.67% vol. 6.76 ± 0.32% vol. 1.40 ± 0.15% wt.
Heart 1.98 ± 0.06% vol. 0.43 ± 0.07% vol. 0.53 ± 0.07% wt.
Liver 7.52 ± 0.36% vol. 6.13 ± 0.54% vol. 4.87 ± 0.34% wt.
Percentage organ volume of the SD mouse embryo (refer to Figure 6) compared
with the percentage organ weight of the adult mouse (averaged across 11
inbred strains) [20] (Mean±Stdv).
Sussman et al. BMC Pregnancy and Childbirth 2013, 13:109 Page 10 of 11
http://www.biomedcentral.com/1471-2393/13/109
changes of those organs. The exact functional effects
remain to be elucidated by post-natal studies. Due to the
genetic similarity between the mouse and the human,
our results could also shed some light on the potential
growth effects on the human fetus, if exposed to a similar
gestational ketogenic diet.
Conclusion
To elucidate some of the possible consequences of mater-
nal KD consumption to fetal growth, we imaged mouse
embryos whose mothers were either on a Standard Diet
(SD) or a Ketogenic Diet (KD) during gestation. Our
data from the SD embryos were compared with currently
available literature on the adult mouse, and reveals a
dramatic change in organ-to-body ratio between E13.5,
E17.5, and adulthood. A comparison between the SD
and KD embryos further indicate marked alterations in
overall embryonic growth, as measured by embryo vol-
ume and organ percentage volume, as well as differ-
ences revealed by deformation analysis within organs;
the brain, spinal cord, pharynx, heart, thymus, and liver.
These growth changes may be a result of embryonic
and organ energy substrate preference, which are mod-
ulated by their concentration in maternal circulation, as
well as their transport across the placenta at the vari-
ous gestational time-points. The drastic drop in mater-
nal blood glucose along with the increase in blood
ketone towards the end of gestation suggest ketones were
the primary energy substrate available for the devel-
oping fetus during its rapid growth phase. As such,
ketones could have been responsible for the altered KD
growth at both time-points, as well as for the rela-
tively hindered KD growth observed at E17.5 compared
with its growth at E13.5. Overall, these growth alter-
ations could be indicative of underlying functional, phys-
iological alterations which could become apparent in
postnatal life.
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